HR 1392
111th Congress
House
Health
Medicare
Prescription drugs
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Introduced: March 9, 2009
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2009
Referred to the Subcommittee on Health.
Mar 9, 2009
Referred to House Ways and Means
Mar 9, 2009
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 9, 2009
Referred to House Energy and Commerce
Mar 9, 2009
Introduced in House
Plain-English summary
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).
Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3